Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 509.6
(3.02%)
INR 509.6
(3.02%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.05 Billion INR | -57.02% |
| 2022 | 2.46 Billion INR | -16.17% |
| 2021 | 2.93 Billion INR | 76.31% |
| 2020 | 1.66 Billion INR | -32.14% |
| 2019 | 2.45 Billion INR | 9.11% |
| 2018 | 2.25 Billion INR | -7.35% |
| 2017 | 2.42 Billion INR | 0.0% |
| 2016 | - INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 792.6 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 1.05 Billion INR | -57.02% |
| 2023 Q4 | 1.05 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.91 Billion INR | 0.0% |
| 2022 Q4 | 2.46 Billion INR | 0.0% |
| 2022 FY | 2.46 Billion INR | -16.17% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.41 Billion INR | 0.0% |
| 2021 FY | 2.93 Billion INR | 76.31% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 2.57 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 2.93 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.66 Billion INR | -32.14% |
| 2020 Q4 | 1.66 Billion INR | 0.0% |
| 2020 Q2 | 2.48 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 2.45 Billion INR | 9.11% |
| 2019 Q4 | 2.45 Billion INR | -23.37% |
| 2019 Q3 | 3.2 Billion INR | 51.71% |
| 2019 Q2 | 2.11 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 2.25 Billion INR | -7.35% |
| 2018 Q2 | 2.6 Billion INR | 0.0% |
| 2018 Q4 | 2.25 Billion INR | 0.0% |
| 2017 Q4 | 2.42 Billion INR | 23.1% |
| 2017 FY | 2.42 Billion INR | 0.0% |
| 2017 Q3 | 1.97 Billion INR | 0.0% |
| 2016 FY | - INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -68.305% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 95.043% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -616.957% |
| Granules India Limited | 689.71 Million INR | -53.441% |
| Indoco Remedies Limited | 3.51 Billion INR | 69.912% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -349.957% |
| Alkem Laboratories Limited | 400 Million INR | -164.575% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -29585.835% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -3701.911% |
| Bajaj HealthCare Limited | 650.34 Million INR | -62.729% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -197.34% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 82.332% |
| Eris Lifesciences Limited | 6.54 Billion INR | 83.831% |
| FDC Limited | 2.46 Million INR | -42815.653% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 30.233% |
| Gufic Biosciences Limited | 1.53 Billion INR | 31.263% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -848.077% |
| Ipca Laboratories Limited | 5.8 Billion INR | 81.766% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -1300.423% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 42.327% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 87.7% |
| Lupin Limited | 1.55 Billion INR | 31.846% |
| Mankind Pharma Limited | 248.67 Million INR | -325.572% |
| Medicamen Biotech Limited | 12.55 Million INR | -8329.311% |
| Medico Remedies Limited | 8.67 Million INR | -12103.644% |
| Megasoft Limited | 1.35 Billion INR | 22.016% |
| NATCO Pharma Limited | 53 Million INR | -1896.792% |
| Piramal Pharma Limited | 24.83 Billion INR | 95.739% |
| RPG Life Sciences Limited | -30.3 Million INR | 3592.739% |
| Sigachi Industries Limited | 265.79 Million INR | -298.16% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -7857.143% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -398.361% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 86917.063% |
| Unichem Laboratories Limited | 382.22 Million INR | -176.882% |
| Wanbury Limited | 820 Million INR | -29.061% |
| Windlas Biotech Limited | 20.18 Million INR | -5144.301% |
| ZIM Laboratories Limited | 356 Million INR | -197.27% |
| Zydus Lifesciences Limited | 251 Million INR | -321.633% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -892.777% |
| Divi's Laboratories Limited | 20 Million INR | -5191.5% |
| Hester Biosciences Limited | 1.81 Billion INR | 41.779% |
| Procter & Gamble Health Limited | 68.8 Million INR | -1438.227% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -7476.604% |
| Bal Pharma Limited | 363.82 Million INR | -190.882% |
| Strides Pharma Science Limited | 6.71 Billion INR | 84.24% |
| Venus Remedies Limited | 386.8 Million INR | -173.604% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -264475.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 24.573% |
| Shilpa Medicare Limited | 5.6 Billion INR | 81.107% |
| Aarti Drugs Limited | 2.75 Billion INR | 61.562% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 89.517% |
| Valiant Laboratories Limited | 746.63 Million INR | -41.744% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -347.673% |
| Themis Medicare Limited | 267.74 Million INR | -295.272% |
| Hikal Limited | 4.22 Billion INR | 74.972% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 93.402% |
| Sequent Scientific Limited | 1.42 Billion INR | 25.847% |
| Novartis India Limited | 50.7 Million INR | -1987.377% |
| Wockhardt Limited | 8.91 Billion INR | 88.122% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 96.658% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -135.593% |
| Morepen Laboratories Limited | 33.64 Million INR | -3045.957% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -692.491% |